http://www.gosreports.com
Global Pharmacovigilance and Drug Safety Software Market To Grow At 6.2% CAGR Over 2016-2020

Increasing incidence rates of adverse drug reactions, growing adoption of pharmacovigilance software by outsourcing companies, and huge pressure on pharma companies to develop novel and safe drugs will foster the Pharmacovigilance and Drug Safety Software market, according to research, the global Pharmacovigilance and Drug Safety Software market is expected to grow at CAGR of 6.2% over 2016-2020.
Geographically, The North America accounted the largest share of global Pharmacovigilance and Drug Safety Software market, region followed by Europe, Europe is expected to register a CAGR of 6.1% for the forecast period. In addition, Asian and Latin American countries symbolize high growth markets. This is owing to a rise in research outsourcing by pharmaceutical giants and growing public and private investments in pharmaceutical R&D in these emerging nations.
Now more than ever, manufacturers must be prepared to adapt to evolving regulatory guidelines and initiatives for drug safety.  That makes broad access to real world evidence vital, and tools that effectively identify and evaluate drug safety issues key to optimizing lifecycles.
Many current methods of signal validation and refinement require costly, labor intensive analyses, leaving manufacturers unprepared to rapidly respond to regulatory inquiries with real world evidence.
Global leading players are ArisGlobal, Ennov Solutions Inc., EXTEDO GmbH, Online Business Applications, Inc., Oracle Corporation, Sarjen Systems Pvt. Ltd, Sparta Systems, Inc., and United BioSource Corporation among others.
Global Pharmacovigilance and Drug Safety Software market share by region as following:

Read Full Report: http://www.gosreports.com/global-pharmacovigilance-and-drug-safety-software-market-research-report-2016/
Joanna | Executive – International Business and partner Relations
E-mail: [email protected] | Tel: 1-510-400-8520
Web: www.gosreports.com
 ________________________________________________

The Full Report:
http://www.gosreports.com/highly-innovative-pipeline-could-transform-obesity-treatment-landscape/
……………………
More Information:
http://www.gosreports.com/asia-pacific-multiple-myeloma-treatment-market-value-will-reach-2-8-billion-by-2021/

Contacts Us
Joanna | Executive - International Business and partner Relations
E-mail: [email protected] 
Tel: 001-510-400-8520
Web: www.gosreports.com